Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Angra PK, Taylor TH, Iademarco MF, Metchock B, Astles JR, Ridderhof JC.

J Clin Microbiol. 2012 Apr;50(4):1233-9. doi: 10.1128/JCM.06479-11. Epub 2012 Feb 1.

2.

Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.

Laszlo A, Rahman M, Espinal M, Raviglione M; WHO/IUATLD Network of Supranational Reference Laboratories.

Int J Tuberc Lung Dis. 2002 Sep;6(9):748-56.

PMID:
12234129
3.
4.

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J.

J Clin Microbiol. 2002 Nov;40(11):3976-9.

6.

Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.

Coban AY, Cihan CC, Bilgin K, Uzun M, Akgunes A, Cetinkaya E, Durupinar B.

Int J Tuberc Lung Dis. 2006 Apr;10(4):450-3.

PMID:
16602412
7.

[Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].

Tuberculosis Research Committee.

Kekkaku. 2007 Mar;82(3):155-64. Japanese.

PMID:
17444118
9.
10.

[Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].

Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z.

Pneumonol Alergol Pol. 2010;78(4):256-62. Polish.

11.
13.
15.

Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

BMC Infect Dis. 2012 Feb 10;12:37. doi: 10.1186/1471-2334-12-37.

16.

Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.

Giampaglia CM, Martins MC, Vieira GB, Vinhas SA, Telles MA, Palaci M, Marsico AG, Hadad DJ, Mello FC, Fonseca Lde S, Kritski A.

Int J Tuberc Lung Dis. 2007 Sep;11(9):986-91.

PMID:
17705976
17.
18.

[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].

Mitarai S, Kobayashi I, Abe C, Wada M, Suzuki K, Takashima T, Kawabe Y, Machida K, Tano M, Takigawa S, Kamada A, Shigetoh E, Fujii S, Mori K, Suyama H, Yano S, Kawashiro T, Ogata H.

Kekkaku. 2007 May;82(5):449-54. Japanese.

PMID:
17564123
19.

Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Hoffner S, Angeby K, Sturegård E, Jönsson B, Johansson A, Sellin M, Werngren J.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1486-90. doi: 10.5588/ijtld.13.0195.

PMID:
24125455
20.

Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis.

Parrish N, Osterhout G, Dionne K, Sweeney A, Kwiatkowski N, Carroll K, Jost KC Jr, Dick J.

J Clin Microbiol. 2007 Dec;45(12):3915-20. Epub 2007 Oct 3.

Supplemental Content

Support Center